ORIX repurchases 17.6M shares totaling JPY 58.25B under 100B program
Rhea-AI Filing Summary
ORIX Corporation disclosed a share repurchase program in an American current report. The company authorized repurchases of common shares up to 100 billion yen, with purchases to occur from May 19, 2025 through March 31, 2026. Under a market purchase arrangement based on a discretionary dealing contract, ORIX bought 17,626,200 shares for a total of JPY 58,252,180,900. The filing specifies the authorization limit, the authorized period, the method (market purchases under a discretionary contract) and the actual repurchased amount and cost.
Positive
- Authorized repurchase amount: up to 100 billion yen
- Clear execution: purchased 17,626,200 shares
- Amount spent disclosed: JPY 58,252,180,900
- Defined timeframe: May 19, 2025 to March 31, 2026
- Execution method stated: market purchases under a discretionary dealing contract
Negative
- None.
Insights
TL;DR: ORIX announced a sizable buyback authorization and has executed material repurchases totaling JPY 58.25 billion.
ORIX's authorization of up to 100 billion yen for repurchases signals capital return via buybacks. The disclosed executed purchases—17,626,200 shares for JPY 58,252,180,900—represent a concrete deployment against that authorization. The use of a discretionary dealing contract for market purchases is a standard execution method that can smooth timing and price execution. This disclosure provides clear figures for the authorization, timeframe and actual repurchased volume and cost.
TL;DR: The repurchase program is governance-aligned capital return; details on authorization, period and execution are clearly reported.
The filing succinctly reports the board-level authorization (up to 100 billion yen), the effective repurchase window (May 19, 2025 to March 31, 2026) and executed purchases under a discretionary contract. Such transparency around method and totals supports shareholder oversight. The document does not provide context on remaining capacity under the authorization or percentage of shares outstanding repurchased, which would aid full governance assessment.
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2025
Commission File Number: 001-14856
ORIX Corporation
(Translation of Registrant’s Name into English)
World Trade Center Bldg., SOUTH TOWER, 2-4-1 Hamamatsu-cho, Minato-ku,
Tokyo, JAPAN
(Address of Principal Executive Offices)
(Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.)
Form 20-F ☒ Form 40-F ☐
Table of Contents
Material Contained in this Report
| 1. |
“Notice regarding Share Repurchase Status” |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ORIX Corporation | ||||
| Date : September 3, 2025 |
By | /s/ Yasuaki Mikami | ||
| Yasuaki Mikami | ||||
| Member of the Board of Directors Senior Managing Executive Officer Responsible for Corporate Function Unit Responsible for Work Style Reform Project ORIX Corporation | ||||
Notice regarding Share Repurchase Status
TOKYO, Japan - September 3, 2025 - ORIX Corporation announced today the status regarding its share repurchase pursuant to the provisions of its Articles of Incorporation and Article 459, Paragraph 1 of the Companies Act, which was resolved at its Board of Directors meeting held on May 12, 2025, as follows.
| 1. Class of shares repurchased |
Common shares | |
| 2. Total number of shares repurchased |
4,680,500 shares | |
| 3. Total purchase price of shares repurchased |
JPY 17,341,974,200 | |
| 4. Repurchase Period |
From August 1, 2025 to August 31, 2025 | |
| 5. Method of share repurchase |
Market purchases based on the discretionary dealing contract regarding repurchase of own shares |
(Reference)
| 1. Details of the resolution reached at the Board of Directors meeting held on May 12, 2025 | ||
| (1) Class of shares to be repurchased |
Common shares | |
| (2) Total number of shares to be repurchased |
Up to 40,000,000 shares (approx. 3.5% of the total outstanding shares (excluding treasury shares)) | |
| (3) Total purchase price of shares to be repurchased |
Up to 100 billion yen | |
| (4) Repurchase Period |
From May 19, 2025 to March 31, 2026 | |
| (5) Method of share repurchase |
Market purchases based on the discretionary dealing contract regarding repurchase of own shares | |
| 2. Cumulative number of shares repurchased based on the above resolution at the Board of Directors Meeting (as of August 31, 2025) | ||
| (1) Total number of shares repurchased |
17,626,200 shares | |
| (2) Total purchase price of shares repurchased |
JPY 58,252,180,900 | |
Contact Information:
Investor Relations and Sustainability Department
ORIX Corporation
Tel: +81-3-3435-3121
About ORIX Group:
ORIX Group (ORIX Corporation TSE: 8591; NYSE: IX) was established in 1964 and has grown from its roots in leasing in Japan to become a global, diverse, and unique corporate group. Today, it is active around the world in financing and investment, life insurance, banking, asset management, real estate, concession, environment and energy, automobile-related services, industrial/ICT equipment, ships and aircraft. Since expanding outside of Japan in 1971, ORIX Group has grown its business globally and now operates in around 30 countries and regions across the world with approximately 34,000 people. ORIX Group unites globally around its Purpose: “Finding Paths. Making Impact.” combining diverse expertise and innovative thinking to help our world develop in a sustainable way. For more details, please visit our website: https://www.orix.co.jp/grp/en/
(As of March 31, 2025)
Caution Concerning Forward-Looking Statements:
These documents may contain forward-looking statements about expected future events and financial results that involve risks and uncertainties. Such statements are based on our current expectations and are subject to uncertainties and risks that could cause actual results that differ materially from those described in the forward-looking statements. Factors that could cause such a difference include, but are not limited to, those described under “Risk Factors” in the Company’s annual report on Form 20-F filed with the United States Securities and Exchange Commission and under “(4) Risk Factors” of the “1. Summary of Consolidated Financial Results” of the “Consolidated Financial Results April 1, 2024 – March 31, 2025” furnished on Form 6-K.
FAQ
What share repurchase authorization did ORIX (IX) disclose?
How many shares has ORIX (IX) repurchased and for what total?
What is the repurchase period ORIX (IX) specified?
What method did ORIX (IX) use to execute the buybacks?
Does the filing state remaining authorization capacity after these purchases?
